{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T03:35:41Z","timestamp":1771644941509,"version":"3.50.1"},"reference-count":91,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T00:00:00Z","timestamp":1691712000000},"content-version":"vor","delay-in-days":4789,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.nurt.2010.05.008","type":"journal-article","created":{"date-parts":[[2010,7,20]],"date-time":"2010-07-20T05:16:52Z","timestamp":1279603012000},"page":"293-301","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Immune Therapy in Autism: Historical Experience and Future Directions with Immunomodulatory Therapy"],"prefix":"10.1016","volume":"7","author":[{"given":"Michael G.","family":"Chez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie","family":"Guido-Estrada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nurt.2010.05.008_bib1","first-page":"1","article-title":"Prevalence of autism spectrum disorders","volume":"58","author":"Rice","year":"2009","journal-title":"MMWR"},{"key":"10.1016\/j.nurt.2010.05.008_bib2","series-title":"American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th edition, text revision","year":"1994"},{"key":"10.1016\/j.nurt.2010.05.008_bib3","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1542\/peds.2005-1516","article-title":"The contribution of diagnostic substitution to the growing administrative prevalence of autism in US special education","volume":"117","author":"Shattuck","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.nurt.2010.05.008_bib4","series-title":"Autistic spectrum disorders: changes in the california caseload: an update 1999\u20132002","year":"2003"},{"key":"10.1016\/j.nurt.2010.05.008_bib5","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1023\/A:1015453830880","article-title":"The changing prevalence of autism in California","volume":"32","author":"Croen","year":"2002","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.nurt.2010.05.008_bib6","series-title":"Report to the legislature on the principle findings from the epidemiology of autism in California","year":"2002"},{"key":"10.1016\/j.nurt.2010.05.008_bib7","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.yebeh.2005.11.001","article-title":"Frequency of epileptiform EEG abnormalities in a sequential screening of autistic patients with no known clinical epilepsy from 1996 to 2005","volume":"8","author":"Chez","year":"2006","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.nurt.2010.05.008_bib8","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1001\/archneur.1988.00520300086024","article-title":"Epilepsy in autism and autisticlike conditions","volume":"45","author":"Olsson","year":"1988","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nurt.2010.05.008_bib9","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.spen.2004.07.003","article-title":"The genetics of autism","volume":"11","author":"Spence","year":"2004","journal-title":"Semin Pediatr Neurol"},{"key":"10.1016\/j.nurt.2010.05.008_bib10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00041444-200106000-00001","article-title":"Chromosomal abnormalities in a clinic sample of individuals with autistic disorder","volume":"11","author":"Wassink","year":"2001","journal-title":"Psychiatr Genet"},{"key":"10.1016\/j.nurt.2010.05.008_bib11","doi-asserted-by":"crossref","first-page":"16834","DOI":"10.1073\/pnas.0605296103","article-title":"A genetic variant that disrupts MET transcription is associated with autism","volume":"103","author":"Campbell","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nurt.2010.05.008_bib12","first-page":"10","article-title":"Pregnancy, immunity, schizophrenia, and autism","volume":"69","author":"Patterson","year":"2006","journal-title":"Eng Sci"},{"key":"10.1016\/j.nurt.2010.05.008_bib13","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0022-3476(99)70248-9","article-title":"Serum auto-antibodies to brain in Landau-Kleffner variant, autism, and other neurologic disorders","volume":"134","author":"Connolly","year":"1999","journal-title":"J Pediatr"},{"key":"10.1016\/j.nurt.2010.05.008_bib14","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/ana.1024","article-title":"Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation","volume":"49","author":"Nelson","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nurt.2010.05.008_bib15","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/02646830500381930","article-title":"Immunity, neuroglia and neuroinflammation in autism","volume":"17","author":"Pardo","year":"2005","journal-title":"Int Rev Psychiatry"},{"key":"10.1016\/j.nurt.2010.05.008_bib16","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/0006-3223(88)90012-1","article-title":"Antibrain antibodies in infantile autism","volume":"23","author":"Todd","year":"1988","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.nurt.2010.05.008_bib17","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/ana.20315","article-title":"Neuroglial activation and neuroinflammation in the brain of patients with autism","volume":"57","author":"Vargas","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nurt.2010.05.008_bib18","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1542\/peds.2008-2445","article-title":"Association of family history of autoimmune diseases and autism spectrum disorders","volume":"124","author":"Atladottir","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.nurt.2010.05.008_bib19","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1177\/088307389901400608","article-title":"Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism","volume":"14","author":"Comi","year":"1999","journal-title":"J Child Neurol"},{"key":"10.1016\/j.nurt.2010.05.008_bib20","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000119223","article-title":"Increased frequency of the extended or ancestral haplotype B44-SC30-DR4 in autism","volume":"32","author":"Daniels","year":"1995","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.nurt.2010.05.008_bib21","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF01531729","article-title":"Immune abnormalities in patients with autism","volume":"16","author":"Warren","year":"1986","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.nurt.2010.05.008_bib22","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.biopsych.2005.07.004","article-title":"Brain-derived neurotrophic factor and auto-antibodies to neural antigens in sera of children with autistic spectrum disorders, Landau-Kleffner syndrome, and epilepsy","volume":"59","author":"Connolly","year":"2006","journal-title":"Biol Psychiat"},{"key":"10.1016\/j.nurt.2010.05.008_bib23","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1006\/clin.1998.4588","article-title":"Serological association of measles virus and human herpesvirus-6 with brain auto-antibodies in autism","volume":"89","author":"Singh","year":"1998","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.nurt.2010.05.008_bib24","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/brbi.1993.1010","article-title":"Antibodies to myelin basic protein in children with autistic behavior","volume":"7","author":"Singh","year":"1993","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.nurt.2010.05.008_bib25","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3109\/08820139009041839","article-title":"Deficiency of suppressor-inducer (CD4+CD45RA+) T cells in autism","volume":"19","author":"Warren","year":"1990","journal-title":"Immunol Invest"},{"key":"10.1016\/j.nurt.2010.05.008_bib26","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF01531114","article-title":"Depressed lymphocyte responsiveness in autistic children","volume":"7","author":"Stubbs","year":"1977","journal-title":"J Autism Child Schizophr"},{"key":"10.1016\/j.nurt.2010.05.008_bib27","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3109\/08820138609094141","article-title":"Reduced natural killer cell activity and OKT4\/OKT8 ratio in epileptic patients","volume":"15","author":"Margaretten","year":"1986","journal-title":"Immunol Invest"},{"key":"10.1016\/j.nurt.2010.05.008_bib28","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/BF02172828","article-title":"Dysregulated immune system in children with autism: beneficial effects of intravenous immune globulin on autistic characteristics","volume":"26","author":"Gupta","year":"1996","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.nurt.2010.05.008_bib29","first-page":"12","article-title":"Immunoglobulin reactivity in autism and Rett's syndrome","volume":"7","author":"Plioplys","year":"1994","journal-title":"Dev Brain Dysfunct"},{"key":"10.1016\/j.nurt.2010.05.008_bib30","first-page":"528","article-title":"Serum immunoglobulins and autoimmune profiles in children with autism","volume":"38","author":"Zimmerman","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nurt.2010.05.008_bib31","first-page":"203","article-title":"Treatment of children with autism with intravenous immunoglobulin","volume":"14","author":"Gupta","year":"1999","journal-title":"J Child Neurol"},{"key":"10.1016\/j.nurt.2010.05.008_bib32","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/088307389801300207","article-title":"Intravenous immunoglobulin treatment of children with autism","volume":"13","author":"Plioplys","year":"1999","journal-title":"J Child Neurol"},{"key":"10.1016\/j.nurt.2010.05.008_bib33","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1086\/302497","article-title":"A genomic screen of autism: evidence for a multilocus etiology","volume":"65","author":"Risch","year":"1999","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.nurt.2010.05.008_bib34","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1017\/S0033291700028099","article-title":"Autism as a strongly genetic disorder: evidence from a British twin study","volume":"25","author":"Bailey","year":"1995","journal-title":"Psychol Med"},{"key":"10.1016\/j.nurt.2010.05.008_bib35","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1086\/342990","article-title":"On the twin risk in autism","volume":"71","author":"Hallmayer","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.nurt.2010.05.008_bib36","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1469-7610.1989.tb00254.x","article-title":"A twin study of autism in Denmark, Finland, Iceland, Norway and Sweden","volume":"30","author":"Steffenburg","year":"1989","journal-title":"J Child Psychol Psych"},{"key":"10.1016\/j.nurt.2010.05.008_bib37","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1002\/ajmg.a.31396","article-title":"Bannayan-Riley-Ruvalcaba syndrome with reactive nodular lymphoid hyperplasia and autism and a PTEN mutation","volume":"140","author":"Boccone","year":"2006","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.nurt.2010.05.008_bib38","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/(SICI)1098-2779(1998)4:2<137::AID-MRDD11>3.0.CO;2-W","article-title":"Possible immunogenetic basis for autism","volume":"4","author":"Burger","year":"1998","journal-title":"Ment Retard Dev D R"},{"key":"10.1016\/j.nurt.2010.05.008_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1189\/jlb.1205707","article-title":"The immune response in autism: a new frontier for autism research","volume":"80","author":"Ashwood","year":"2006","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.nurt.2010.05.008_bib40","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1523\/JNEUROSCI.23-01-00297.2003","article-title":"Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring","volume":"23","author":"Shi","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.nurt.2010.05.008_bib41","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.neures.2006.06.002","article-title":"Recent progress in animal modeling of immune inflammatory processes in schizophrenia: implication of specific cytokines","volume":"56","author":"Nawa","year":"2006","journal-title":"Neurosci Res"},{"issue":"Pt 12","key":"10.1016\/j.nurt.2010.05.008_bib42","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1093\/brain\/awh287","article-title":"Neuropathological findings in autism","volume":"127","author":"Palmen","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.nurt.2010.05.008_bib43","series-title":"Modeling features of autism in animals","author":"Patterson","year":"2005"},{"key":"10.1016\/j.nurt.2010.05.008_bib44","doi-asserted-by":"crossref","first-page":"10695","DOI":"10.1523\/JNEUROSCI.2178-07.2007","article-title":"Maternal immune activation alters fetal brain development through interleukin-6","volume":"27","author":"Smith","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.nurt.2010.05.008_bib45","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0920-9964(00)00032-3","article-title":"Prenatal exposure to maternal infection alters cytokine expression in the placenta, amniotic fluid, and fetal brain","volume":"47","author":"Urakubo","year":"2001","journal-title":"Schizophr Res"},{"key":"10.1016\/j.nurt.2010.05.008_bib46","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/sj.mp.4002042","article-title":"Adult behavioral and pharmacological dysfunctions following disruption of the fetal brain balance between pro-inflammatory and IL-10-mediated anti-inflammatory signaling","volume":"13","author":"Meyer","year":"2008","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.nurt.2010.05.008_bib47","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1177\/08830738020170111501","article-title":"Double-blind, placebo-controlled study of L-carnosine supplementation in children with autistic spectrum disorders","volume":"17","author":"Chez","year":"2002","journal-title":"J Child Neurol"},{"key":"10.1016\/j.nurt.2010.05.008_bib48","first-page":"S116","article-title":"Fetal anti-brain anti-bodies in serum of mothers of children with autistic disorder: correlation with developmental regression","volume":"62","author":"Morris","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nurt.2010.05.008_bib49","series-title":"Maternal antibodies and placental-fetal IgG transfer theory","author":"Morris","year":"2008"},{"key":"10.1016\/j.nurt.2010.05.008_bib50","article-title":"Serum anti-brain antibody differences in mothers of children with autism disorder: a study with fetal human and rodent tissue","author":"Singer","year":"2007","journal-title":"International Meeting for Autism Research (IMFAR)"},{"key":"10.1016\/j.nurt.2010.05.008_bib51","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.bbi.2006.08.005","article-title":"Maternal antibrain antibodies in autism","volume":"21","author":"Zimmerman","year":"2007","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.nurt.2010.05.008_bib52","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/archpedi.159.2.151","article-title":"Maternal autoimmune diseases, asthma and allergies, and childhood autism spectrum disorders: a case-control study","volume":"159","author":"Croen","year":"2005","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.nurt.2010.05.008_bib53","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.pediatrneurol.2007.01.012","article-title":"Elevation of tumor necrosis factor-alpha in cerebrospinal fluid of autistic children","volume":"36","author":"Chez","year":"2007","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.nurt.2010.05.008_bib54","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0165-5728(00)00317-9","article-title":"Role of NMDA receptor signaling in the regulation of inflammatory gene expression after focal brain ischemia","volume":"109","author":"Jander","year":"2000","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.nurt.2010.05.008_bib55","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1212\/WNL.57.9.1618","article-title":"Postmortem brain abnormalities of the glutamate neurotransmitter system in autism","volume":"57","author":"Purcell","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2010.05.008_bib56","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1093\/ajcn\/80.6.1611","article-title":"Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism","volume":"80","author":"James","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.nurt.2010.05.008_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuro.2004.07.012","article-title":"Thimerosal neurotoxicity is associated with glutathione depletion: protection with glutathione precursors","volume":"26","author":"James","year":"2005","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.nurt.2010.05.008_bib58","first-page":"544","article-title":"Superoxide dismutase overactivity, excessive selenium, and low copper in acquired epileptic aphasia (the Landau-Kleffner syndrome)","volume":"39","author":"Chez","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nurt.2010.05.008_bib59","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ajog.2005.06.082","article-title":"N-acetyl-cysteine suppresses amniotic fluid and placenta inflammatory cytokine responses to lipopolysaccharide in rats","volume":"194","author":"Beloosesky","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.nurt.2010.05.008_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1535-7597.2005.05101.x","article-title":"Inflammation and epilepsy","volume":"5","author":"Vezzani","year":"2005","journal-title":"Epilepsy Curr"},{"key":"10.1016\/j.nurt.2010.05.008_bib61","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1111\/j.1528-1167.2005.00298.x","article-title":"Brain inflammation in epilepsy: experimental and clinical evidence","volume":"46","author":"Vezzani","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.nurt.2010.05.008_bib62","first-page":"217","article-title":"Treatment of electroencephalographic epileptiform activity on overnight EEG studies in children with pervasive developmental disorder or autism: defining similarities to the Landau-Kleffner syndrome","volume":"2","author":"Chez","year":"1998","journal-title":"J Dev Learning Disord"},{"key":"10.1016\/j.nurt.2010.05.008_bib63","doi-asserted-by":"crossref","first-page":"530","DOI":"10.4088\/JCP.v62n07a05","article-title":"An open trial of divalproex sodium in autism spectrum disorders","volume":"62","author":"Hollander","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.nurt.2010.05.008_bib64","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1001\/archpedi.1994.02170020106021","article-title":"Autism: electroencephalogram abnormalities and clinical improvement with valproic acid","volume":"148","author":"Plioplys","year":"1994","journal-title":"Arch Pediat Adol Med"},{"key":"10.1016\/j.nurt.2010.05.008_bib65","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1067\/mpd.2000.105355","article-title":"Response to steroid therapy in autism secondary to autoimmune lymphoproliferative syndrome","volume":"136","author":"Shenoy","year":"2000","journal-title":"J Pediatr"},{"key":"10.1016\/j.nurt.2010.05.008_bib66","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1086\/313623","article-title":"Relief of psychiatric symptoms in a patient with Crohn's disease after metronidazole therapy","volume":"30","author":"Sandler","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.nurt.2010.05.008_bib67","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1177\/088307380001500701","article-title":"Short-term benefit from oral vancomycin treatment of regressive-onset autism","volume":"15","author":"Sandler","year":"2000","journal-title":"J Child Neurol"},{"key":"10.1016\/j.nurt.2010.05.008_bib68","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/13590840600681827","article-title":"Improvement in children with autism treated with intravenous gamma globulin","volume":"15","author":"Boris","year":"2005","journal-title":"J Nutr Environ Med"},{"issue":"Suppl 7","key":"10.1016\/j.nurt.2010.05.008_bib69","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1528-1167.2009.02221.x","article-title":"Landau-Kleffner syndrome and CSWS syndrome: treatment with intravenous immunoglobulins","volume":"50","author":"Arts","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.nurt.2010.05.008_bib70","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/j.1528-1157.2000.tb00257.x","article-title":"Successful use of intravenous immunoglobulin as initial monotherapy in Landau-Kleffner syndrome","volume":"41","author":"Mikati","year":"2000","journal-title":"Epilepsia"},{"issue":"3 Pt 1","key":"10.1016\/j.nurt.2010.05.008_bib71","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1542\/peds.104.3.405","article-title":"Magnetoencephalographic patterns of epileptiform activity in children with regressive autism spectrum disorders","volume":"104","author":"Lewine","year":"1999","journal-title":"Pediatrics"},{"key":"10.1016\/j.nurt.2010.05.008_bib72","series-title":"New developments in child neurology","article-title":"Practical treatment with pulse-dose corticosteroids in pervasive developmental disorder of autistic patients with abnormal sleep EEG and language delay","author":"Chez","year":"1998"},{"key":"10.1016\/j.nurt.2010.05.008_bib73","first-page":"539","article-title":"Pulse high-dose steroids as combination therapy with valproic acid in epileptic aphasia patients with pervasive developmental delay or autism","volume":"44","author":"Chez","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nurt.2010.05.008_bib74","first-page":"66","article-title":"Developmental aphasia with epileptiform abnormalities on EEG: clinical features and response to Prednisone","volume":"52","author":"Trauner","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nurt.2010.05.008_bib75","article-title":"Patterns of epileptiform activity and clinical response to steroid therapy in autism","author":"Lewine","year":"2009","journal-title":"International Meeting for Autism Research (IMFAR)"},{"key":"10.1016\/j.nurt.2010.05.008_bib76","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0896-6974(96)00026-6","article-title":"Pulse methylprednisolone therapy in Landau-Kleffner syndrome","volume":"9","author":"Aykut-Bingol","year":"1998","journal-title":"J Epilepsy"},{"key":"10.1016\/j.nurt.2010.05.008_bib77","series-title":"Treatment of Landau-Kleffner syndrome with pulse dose prednisone: behavioral and language outcomes","author":"Hempel","year":"2009"},{"key":"10.1016\/j.nurt.2010.05.008_bib78","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1097\/00004583-199508000-00022","article-title":"Case study: corticosteroid treatment of language regression in pervasive developmental disorder","volume":"34","author":"Stefanatos","year":"1995","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.nurt.2010.05.008_bib79","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/0006-3223(92)90156-T","article-title":"The use of adrenocorticotrophic hormone (4\u20139) analog ORG 2766 in autistic children: effects on the organization of behavior","volume":"31","author":"Buitelaar","year":"1992","journal-title":"Biol Psychiat"},{"key":"10.1016\/j.nurt.2010.05.008_bib80","unstructured":"Chez M. Effect of Lenalidomide on TNF-alpha elevation and behavior in autism. Presented at: International Meeting for Autism Research (IMFAR); May 20\u201322, 2010; Philadelphia, PA."},{"key":"10.1016\/j.nurt.2010.05.008_bib81","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1742-2094-4-3","article-title":"Effect of pioglitazone treatment on behavioral symptoms in autistic children","volume":"4","author":"Boris","year":"2007","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.nurt.2010.05.008_bib82","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1365-2362.2006.01657.x","article-title":"Role of the pro-inflammatory cytokines TNF-alpha and IL-1beta in HIV-associated dementia","volume":"36","author":"Brabers","year":"2006","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.nurt.2010.05.008_bib83","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1742-2094-5-2","article-title":"Rapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration","volume":"5","author":"Tobinick","year":"2008","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.nurt.2010.05.008_bib84","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/13554799508402352","article-title":"Reversible Behavioral autistic-like regression: a manifestation of a special (new?) Epileptic syndrome in a 28 month old child","volume":"1","author":"Deonna","year":"1995","journal-title":"Neurocase"},{"key":"10.1016\/j.nurt.2010.05.008_bib85","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/npp.2009.202","article-title":"Divalproex sodium vs placebo for the treatment of irritability in children and adolescents with autism spectrum disorders","volume":"35","author":"Hollander","year":"2010","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.nurt.2010.05.008_bib86","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMoa0803531","article-title":"Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs","volume":"360","author":"Meador","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nurt.2010.05.008_bib87","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1176\/appi.ajp.161.11.2115","article-title":"A pilot study of D-cycloserine in subjects with autistic disorder","volume":"161","author":"Posey","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.nurt.2010.05.008_bib88","first-page":"254","article-title":"Double-blind, placebo-controlled study of amantidine hydrochloride in the treatment of children with autistic disorder","volume":"184","author":"King","year":"2001","journal-title":"J Am Acad Child Psy"},{"key":"10.1016\/j.nurt.2010.05.008_bib89","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1089\/cap.2006.16.517","article-title":"A prospective, open-label trial of memantine in the treatment of cognitive, behavioral, and memory dysfunction in pervasive developmental disorders","volume":"16","author":"Owley","year":"2006","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.nurt.2010.05.008_bib90","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1177\/0883073807302611","article-title":"Memantine as adjunctive therapy in children diagnosed with autistic spectrum disorders: an observation of initial clinical response and maintenance tolerability","volume":"22","author":"Chez","year":"2007","journal-title":"J Child Neurol"},{"key":"10.1016\/j.nurt.2010.05.008_bib91","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s00213-005-0246-6","article-title":"N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder","volume":"184","author":"Lafleur","year":"2006","journal-title":"Psychopharmacology (Berl)"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923002258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923002258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1016\/j.nurt.2010.05.008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:35:36Z","timestamp":1761806136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923002258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":91,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S1878747923002258"],"URL":"https:\/\/doi.org\/10.1016\/j.nurt.2010.05.008","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune Therapy in Autism: Historical Experience and Future Directions with Immunomodulatory Therapy","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nurt.2010.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}